In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EHJ - Cardiovascular Pharmacotherapy

Specific focus on clinical cardiovascular pharmacology

 

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.

It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.

 

Fast Facts

  • Editor-in-Chief: Stefan Agewall FESC, NO
  • Current volume: 5 (year 2019)
  • Issues per subscription: 4
  • Impact Factor 2018: 6.723
Updates on latest articles

Updates on latest articles

 

Receive Table of contents in your mailbox.

Track the topics, authors and articles important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blinded peer review by experienced international experts.


Most recent articles from EHJ-CVP

18 Jun 2019
Antiplatelet treatment in acute coronary syndrome. Still an issue
Author(s):Agewall S.
14 Mar 2019
Should we consider early de-escalation of maintenance dose of antiplatelet therapy post-ACS?
Author(s):Held C.
23 May 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Author(s):Sulzgruber P, Wassmann S, Semb A, et al.
13 Mar 2019
A gradient of benefit of beta-blockers in acute coronary syndrome patients: from severely depressed ejection fraction up to the normal level
Author(s):Montenegro Sá F, Morais J.